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GDF11, a new member of the TGF-b gene superfamily, regulates anterior/posterior patterning in the axial skeleton during
ouse embryogenesis. Gdf11 null mice display skeletal abnormalities that appear to represent anterior homeotic
ransformations of vertebrae consistent with high levels of Gdf11 expression in the primitive streak, presomitic mesoderm,
and tail bud. However, despite strong Gdf11 expression in the limb throughout development, this structure does not appear
to be affected in the knockout mice. In order to understand this dichotomy of Gdf11 expression versus Gdf11 function, we
dentified the chicken Gdf11 gene and studied its role during limb formation. In the early limb bud, Gdf11 transcripts are
detected in the subectodermal mesoderm at the distal tip, in a region overlapping the progress zone. At these stages, Gdf11
is excluded from the central core mesenchyme where precartilaginous condensations will form. Later in development,
Gdf11 continues to be expressed in the distal most mesenchyme and can also be detected more proximally, in between the
forming skeletal elements. When beads incubated in GDF11 protein were implanted into the early wing bud, GDF11 caused
severe truncations of the limb that affected both the cartilage elements and the muscle. Limb shortening appeared to be the
result of an inhibition of chondrogenesis and myogenesis and using an in vitro micromass assay, we confirmed the negative
effects of GDF11 on both myogenic and chondrogenic cell differentiation. Analysis of molecular markers of skeletal
patterning revealed that GDF11 induced ectopic expression of Hoxd-11 and Hoxd-13, but not of Hoxa-11, Hoxa-13, or the
Msx genes. These data suggest that GDF11 may be involved in controlling the late distal expression of the Hoxd genes
uring limb development and that misregulation of these Hox genes by excess GDF11 may cause some of the observed
lterations in skeletal element shape. In addition, GDF11 induced the expression of its own antagonist follistatin, indicating
hat the activity of GFD11 may be limited by a negative feedback mechanism. The data from our studies in the chick suggest
hat Gdf11 plays a role in the formation and development of the avian limb skeleton. © 2000 Academic Press
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Bone morphogenetic proteins (BMPs) and the closely
related growth and differentiation factors (GDFs) are mem-
bers of the TGF-b superfamily of peptide growth factors
hat function as regulators of cell proliferation, pro-
rammed cell death, terminal differentiation, and specifica-
ion of developmental fate (Hogan, 1996). BMPs were origi-
ally isolated by their ability to form ectopic cartilage and
one in adult animals and have proven to be key molecules
or bone growth and repair in the adult skeleton (Wozney et
l., 1988; Gamer and Rosen, 2000). BMPs exert their bio-
ogical effects by signaling through type I and type II
1 To whom correspondence should be addressed. Fax: (617) 665-
e7516. E-mail: lgamer@genetics.com.
0012-1606/00 $35.00
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All rights of reproduction in any form reserved.erine–threonine kinase receptors to the nucleus via the
mad gene family (Whitman, 1998). The activity of BMPs
an be modulated by a growing list of antagonist proteins,
ncluding noggin, chordin, follistatin, and gremlin, that
ind to a BMP, preventing it from interacting with its
eceptor (Thomsen, 1997).
GDF11 is a recently identified member of the TGF-b
family that is most closely related to GDF8 (myostatin), a
negative regulator of muscle growth (McPherron et al.,
1997). In the mouse embryo, Gdf11 is first detected in
egions where new mesodermal cells arise, such as the
rimitive streak and tail bud (Gamer et al., 1999; Na-
ashima et al., 1999; McPherron et al., 1999). As develop-
ment proceeds, Gdf11 shows strong expression in the
ranchial arches, limb buds, and dorsal neural tube (Gamer
t al., 1999; Nakashima et al., 1999; McPherron et al.,
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408 Gamer et al.1999). In late stage embryos, Gdf11 is also found in termi-
nally differentiated odontoblasts, the nasal epithelium, the
retina, and the brain (Nakashima et al., 1999). Mice ho-
mozygous for a targeted deletion of Gdf11 exhibited exten-
sive axial skeletal patterning defects as well as renal and
palate abnormalities. The Gdf11 knockout mice have an
longated trunk and a reduced or absent tail which appears
o be the result of the formation of additional thoracic and
umbar vertebrae (McPherron et al., 1999). The mutant
henotype is thought to be due to a broad homeotic trans-
ormation of vertebrae to more anterior developmental fates
McPherron et al., 1999). This also results in alterations in
he expression pattern of several Hox genes in the mutant
ice, suggesting that Gdf11 acts upstream of these tran-
cription factors during axial patterning (McPherron et al.,
999). Thus, GDF11 is thought to be one of the first
ecreted molecules directly involved in the global specifi-
ation of positional identity along the anterior–posterior
FIG. 1. Expression of Gdf11 during early chick limb developmen
in the limbs from stage 19 to 27. Except for D, anterior is to the top
at the tip of the developing forelimb and hindlimb buds at stage 19
root ganglia at this stage. (B) Expression of Gdf11 in the wing bud a
from the AER. (C) Expression of Gdf11 in stage 22/23 wing bud. Gd
highest expression levels at the anterior. Gdf11 appears to be exclu
22 hindlimb bud showing the absence of Gdf11 in the central prec
showing the restriction of Gdf11 to the subectodermal mesenchy
(arrowhead). (F and G) Expression of Gdf11 in stage 25 limbs. Wi
mesenchyme of the developing autopod. Gdf11 transcripts can b
(arrowheads). (H and I) Expression of Gdf11 in stage 26/27 limb
mesenchyme surrounding the digits and the mesenchyme aroundody axis. p
Copyright © 2000 by Academic Press. All rightIt is clear from functional studies in the mouse that
df11 plays an important role in the proper formation of
he axial skeleton. Using Xenopus embryos, we showed
hat GDF11 was a potent mesoderm inducer that could be
pecifically inhibited by the activin/BMP antagonist, fol-
istatin (Gamer et al., 1999). Since both Gdf11 and follista-
in are expressed in the limb during skeletogenesis, we were
nterested in determining why this structure was unaf-
ected in the Gdf11 knockout mice. To begin to understand
he role of Gdf11 in the appendicular skeleton, we analyzed
ts expression pattern and function in the developing chick
imb. Gdf11 is highly expressed in distal mesenchyme of
he limb bud, but excluded from the central core prechon-
rogenic mesenchyme. Implantation of beads soaked in
DF11 protein into early wing buds caused a dramatic
hortening of the limbs. The truncation appeared to be due
o inhibition of both chondrogenesis and myogenesis, as
ell as to an increase in apoptosis in the affected limbs. The
ole-mount in situ hybridization showing the expression of Gdf11
distal is to the right. (A) Gdf11 expression in the distal mesoderm
e that Gdf11 is also highly expressed in the neural tube and dorsal
e 21. Transcripts localize to the distal mesenchyme and are absent
anscripts in the subectodermal mesenchyme are in a gradient with
rom the posterior-proximal mesoderm. (D) Posterior view of stage
rogenic mesenchyme. (E) Section through a stage 23/24 hindlimb
nd the lack of Gdf11 in the central core mesenchyme and AER
d (F) and leg bud (G) show strong Gdf11 expression in the distal
tected in proximal stripes adjacent to the developing cartilages
the wing bud (H) and leg bud (I), Gdf11 localizes to the distal
eveloping skeletal elements (arrowheads).t. Wh
and
. Not
t stag
f11 tr
ded f
hond
me a
ng bu
e de
s. Inhenotype of the GDF11 wings was similar to what has
s of reproduction in any form reserved.
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409Gdf11 Is a Negative Regulator in Developing Chick Limbbeen previously reported for the misexpression of Hoxd-11
and Hoxd-13 in the early chick limb (Goff and Tabin, 1997).
We found that GDF11 induced the ectopic expression of
both of these genes. These data suggest that Gdf11 may
egulate the late distal expression of Hox genes during the
rowth and differentiation of the limb skeleton. Interest-
ngly, GDF11 also caused the ectopic expression of follista-
in, indicating that its activity may be controlled by a
egative feedback mechanism with its own antagonist.
FIG. 2. Skeletal alterations induced by implantation of GDF11
implanted into the forelimb bud at stage 20–22. For skeletal analy
day 5 (A), day 7 (B and C), and day 8 (D and E) embryos, stained with
beads causes a significant decrease in the size of the limb bud com
control wing is on top and the GDF11-treated wing is on the botto
pattern of a day 7 GDF11-treated wing implanted at stage 20. The h
appear normal. (D) Normal skeletal pattern of a control wing at day
21. The humerus, radius, and ulna are all reduced in length and wi
arrowheads in A, C, and E show the location of the bead. h, humerom studies in the chick, we conclude that Gdf11 may
Copyright © 2000 by Academic Press. All rightlay an important role in the formation and patterning of
he limb in the avian embryo.
MATERIALS AND METHODS
Cloning Chick GDF-11
The chick Gdf11 gene was isolated by screening a 5-day chicken
embryo cDNA library (Stratagene) with a probe derived from the
in the early wing bud. Beads incubated in GDF11 protein were
ontralateral control and GDF11-treated wings were isolated from
n blue, and cleared with KOH-glycerol. (A) Implantation of GDF11
d to the contralateral control at day 5 (24 h) after treatment. The
B) Normal skeletal pattern of a control wing at day 7. (C) Skeletal
rus is shortened and widened while the radius, ulna, and digits all
) Skeletal pattern of a day 8 GDF11-treated wing implanted at stage
ote the fusion of the radius and ulna at their proximal ends. The
r, radius; u, ulna.beads
sis, c
Alcia
pare
m. (
ume
8. (E
der. Npropeptide region of mouse Gdf11 using standard conditions.
s of reproduction in any form reserved.
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410 Gamer et al.Hybridizations were carried out overnight at 45°C using QuikHyb
solution (Stratagene) and membranes were washed at a final
stringency of 13 SSC, 0.1% SDS at 55°C. A partial cDNA clone
was isolated whose identity as chicken Gdf11 was confirmed by
DNA sequence analysis comparing chick DNA sequences with the
reported sequences for human and mouse Gdf11 (Gamer et al.,
1999). A region corresponding to the propeptide of chick Gdf11 was
subcloned into pBluescript (Stratagene). An antisense riboprobe
was generated by digesting the construct with EcoRI and transcrib-
ing with T7 polymerase.
Embryos
Embryos were obtained by incubating fertilized White Leghorn
chicken eggs (SPAFAS) at 39°C and staged according to Hamburger
and Hamilton (1951).
In Situ Hybridizations
Embryos were fixed in 4% paraformaldehyde in PBS overnight at
4°C and processed for whole-mount in situ hybridization as de-
cribed in Riddle et al. (1993). Whole-mount embryos were pro-
essed, embedded in paraffin, and sectioned as in Nieto et al.
1996). Plasmids containing probes for Hoxa-11, Hoxa-13, Hoxd-11,
oxd-13, Msx1, Msx2, MyoD, and Pax3 were kindly provided by
liff Tabin. The probe for chicken follistatin was obtained by
T-PCR using primers and conditions as described in Merino et al.
1999a).
Experimental Manipulation of the Limbs
Eggs were windowed at the appropriate stage and the limb buds
were exposed. Affi-Gel blue beads (Bio-Rad) of a diameter ranging
from 100 to 150 mm were washed in PBS and incubated for 1 h at
room temperature in human recombinant GDF11 at a concentra-
tion of 0.5 mg/ml. Beads were implanted in the distal mesenchyme
subadjacent to the apical ectodermal ridge (AER) of stage 20 wing
buds through incisions made by tungsten dissection needles. After
the operation, eggs were returned to the incubator for the desired
length of time.
Morphological Analysis of Limbs
The skeletal morphology of the limbs was studied in whole-
mount specimens after cartilage staining with Alcian blue. Bead-
implanted embryos that had developed to the appropriate stage
were fixed in 4% paraformaldehyde in PBS overnight at 4°C.
Embryos were rinsed several times in PBS and stained for 5 h with
Alcian blue solution (0.02% Alcian blue 8GX dissolved in a
mixture of 70% ethanol and 30% glacial acetic acid). After staining
was complete, embryos were washed in 70% ethanol and distilled
water for 1 h each before processing through a 0.5% potassium
hydroxide:glycerol series (3:1, 1:1, 1:3) for 2 h at each step and
finally stored in 100% glycerol.
For histology, stained whole skeletal preparations of control and
GDF11-treated wings were processed back through the potassium
hydroxide:glycerol series (1:3, 1:1, 3:1) and then rinsed in H2O. The
ings were then embedded in JB4 resin (PolyScience) and 5-mm
sections were collected and analyzed by light microscopy.
Copyright © 2000 by Academic Press. All rightAnalysis of Apoptosis and Cell Proliferation
The distribution of cell death was analyzed at 24 h by TdT-
mediated dUTP nick end labeling (TUNEL). Immunohistochemical
detection of cells undergoing apoptosis was performed on paraffin-
sectioned GDF11 bead-implanted and control bead-implanted limb
buds using the in situ cell death detection kit (Boehringer Mann-
heim) according to the manufacturer’s directions.
To assess changes in cell proliferation, bromodeoxyuridine
(BrdU) incorporation analyses were performed exactly as described
in Zou et al. (1997).
Micromass Cultures
High-density microtiter micromass cultures were carried out as
described in Daniels et al. (1996), using stage 23/24 forelimb buds.
Recombinant human GDF11 was initially tested at concentrations
ranging from 100 to 1000 ng/ml and a dose of 250 ng/ml was chosen
for experiments as it gave the most consistent results. Recombi-
nant human BMP-2 was also used at a concentration of 250 ng/ml.
Media and growth factors were changed every day. The cultures
were stained with Alcian blue (pH 1.0) to visualize chondrogenic
nodule formation (Lev and Spicer, 1964). To detect myogenic cells,
cultures were stained with MF-20, a monoclonal antibody specific
for sarcomeric myosin (Developmental Studies Hybridoma Bank)
using an anti-mouse IgG Vectastain Elite ABC kit (Vector Labora-
tories).
RESULTS
Cloning and Embryonic Limb Expression
of Chicken Gdf11
To further understand the role of Gdf11 in vertebrate
development, we screened a day 5 chicken embryo cDNA
library and isolated a novel cDNA that upon sequencing
was shown to encode chicken Gdf11. In the carboxy-
terminal mature region, chicken GDF11 protein has 99%
identity to mouse and human GDF11 (data not shown).
The expression of Gdf11 during chick limb bud develop-
ment was determined by whole-mount in situ hybridiza-
ion. Gdf11 is initially expressed at stage 19 in the distal
esoderm at the tip of the limb bud (Fig. 1A). At stages
0–22, Gdf11 transcripts localize to subectodermal mesen-
chyme where they are expressed in a gradient, with highest
levels more anterior and little or no expression in the
proximal-posterior mesoderm of the bud (Figs. 1B–1E). At
these and later stages, Gdf11 is not detected in the AER or
he central core prechondrogenic mesenchyme (Figs. 1C–
E). From stages 24–27, Gdf11 continues to be strongly
expressed in the distal most mesoderm of the developing
autopod (Figs. 1F–1I). At stage 25, Gdf11 transcripts can be
detected more proximally in stripes of mesenchyme that
flank the condensing cartilages (see arrowheads in Figs.
1G–1I). We found similar expression patterns of Gdf11 in
both the developing wing and leg. Our results reveal that
Gdf11 has a dynamic localization pattern during limb
formation, being highly expressed in the distal progress
zone mesenchyme and excluded from the prechondrogenic
s of reproduction in any form reserved.
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411Gdf11 Is a Negative Regulator in Developing Chick Limbmesenchyme that will eventually form the skeletal ele-
ments.
Gdf11 Causes Truncations of Skeletal Elements
in the Limb
The potential role of Gdf11 during early limb develop-
ment was investigated by implanting beads incubated in
GDF11 protein into the distal mesoderm of stage 20–22
chick wing buds (n 5 110). This treatment resulted in
localized reductions of skeletal structures within the limb.
The phenotype was clearly detectable after 24 h as a
decrease in the size of the limb bud along all three axes (Fig.
2A). When embryos were allowed to develop further (from 7
to 11 days), skeletal preparations of the treated wings
revealed a dramatic shortening and widening of the limb
elements in both the stylopod and the zeugopod (Figs. 2C
and 2E). The length of the cartilage in the autopod was
almost always normal. The particular proximal–distal skel-
etal element affected depended on the stage at which the
limb was treated. If the bead was placed in the wing bud at
stage 20, the humerus was most frequently truncated (com-
pare Fig. 2C to Fig. 2B). When the bead was implanted at
stage 21–22 and its final location was the joint region, the
humerus, radius, and ulna were all shortened (compare Fig.
2E to Fig. 2D). Figure 2E demonstrates the additional
cartilage phenotype we often observed in these limbs, a
fusion of the radius and ulna at their proximal end. The
affected skeletal elements in the GDF11-treated wings were
anywhere from 50 to 85% the length of the contralateral
controls. Although the size of the skeletal elements was
altered, their patterning appeared normal and all the carti-
lage elements were present within the GDF11 wings. Al-
most all of the GDF11-treated embryos displayed some
recognizable limb alteration and these effects were never
seen in control limbs implanted with beads soaked in PBS.
The observed truncation of the skeletal elements in the
GDF11-treated limbs could result from changes in cell
proliferation, cell death, or cell differentiation. To investi-
gate the first possibility, BrdU-incorporation analysis was
performed on limbs 24 and 48 h after implantation with
GDF11 beads. No differences in the labeling of proliferating
cells either around the bead or in other regions of the limb
were detected between control and GDF11-treated wings
(n 5 5) (data not shown).
Increases in programmed cell death in the early limb bud
ould also play a role in the observed truncations of skeletal
lements, due to a reduction in the number of mesenchy-
al cells needed to form the limb. Since BMPs have been
hown to be potent apoptotic signals for the undifferenti-
ted limb mesenchyme (Zou and Niswander, 1996; Ganan
t al., 1996), we performed TUNEL assays on GDF11
ead-implanted limbs. We found a high localized concen-
ration of TUNEL-positive cells surrounding the GDF11
ead after 24 h (n 5 5) compared to contralateral control
ing buds (Figs. 3A–3D). We did not detect any significantncrease in cell death in wing buds treated with control h
Copyright © 2000 by Academic Press. All righteads soaked in PBS, indicating that bead implantation
tself does not cause apoptosis in the manipulated limbs
Fig. 3F). Our data suggest that some of the reductions seen
n the cartilage elements of GDF11-treated wings could be
ue to increases in cell death and that GDF11, like BMPs 2,
, and 7, can induce apoptosis in the early limb bud.
To investigate the effects of GDF11 on cell differentia-
ion, we used micromass cultures of dissociated chick wing
ud mesenchyme. When these cells are plated at high
ensity, they spontaneously differentiate to form cartilage
nd muscle (Swalla and Solursh, 1986) and are a useful in
itro model for studying chondrogenesis. Micromass cul-
ures were made from stage 23–24 wing buds and incubated
or 3 days in the presence or absence of 250 ng/ml GDF11 or
MP-2. The cells were then assayed for changes in chon-
rogenesis by Alcian blue staining, which detects sulfated
roteoglycans deposited in the cartilage matrix. As seen in
ig. 4A, control, untreated cultures formed many Alcian
lue-positive cartilage nodules. The BMP-2-treated cultures
howed enhanced chondrogenesis, forming sheet-like con-
ensations of cartilage that were darkly stained with Alcian
lue (Fig. 4B). In contrast, cultures treated with GDF11
howed very little Alcian blue staining, indicating that
artilage formation had been inhibited (Fig. 4C). These data
uggest that GDF11 has a strong negative effect on the
hondrogenic differentiation of limb mesenchyme in vitro.
To investigate the inhibitory effect of GDF11 on chon-
rogenesis in vivo, we performed histological analyses on
ections from day 8–9 skeletal preparations from contralat-
ral control and treated wings (n 5 4). In normal avian
artilage (Figs. 5A–5D), chondrocytes are arranged in three
istinct zones with quiescent, rounded cells in the epiphy-
es (Fig. 5B); proliferative, flattened cells in the metaphyseal
egion (Fig. 5C); and hypertrophic chondrocytes in the
iaphyseal region (Fig. 5D). In the severely affected GDF11-
reated humerus (Figs. 5E–5H), the characteristic zones of
hondrocytes are lost. Most cells within the cartilage ele-
ent are round and the small number of flattened cells that
an be found are not arranged in normal ordered rows (Fig.
G). Although the central core chondrocytes of the diaphy-
is have some denser staining matrix, they do not appear to
ave undergone hypertrophy or formed distinct lacunae
Fig. 5H). Chondrogenesis appears delayed in the GDF11-
reated wings, suggesting that the observed truncation of
he skeletal elements may be due, in part, to an inhibition
f chondrocyte cell differentiation.
Gdf11 Inhibits Muscle Development
Mature GDF11 shares 90% amino acid identity with
GDF8, a potent negative regulator of skeletal muscle. The
fact that these two proteins are so highly related and have
very similar activities in vivo and in vitro (N. Wolfman, S.
hies, and L. Gamer unpublished observations) raises the
ossibility that GDF11 and GDF8 could signal through the
ame receptor. This led us to wonder if GDF11 could also
ave an inhibitory effect on limb muscle formation. To
s of reproduction in any form reserved.
ted in
412 Gamer et al.investigate this possibility, we implanted beads incubated
in GDF11 protein into stage 20–21 wing buds and looked
for changes in the expression patterns of Pax3 and MyoD,
markers of proliferating and differentiating myogenic cells,
respectively (Olson, 1992; Williams and Ordahl, 1994), 24
and 48 h after treatment. In the most severely truncated
limbs, GDF11 caused a complete inhibition of Pax3 and
MyoD expression (compare Figs. 6B to 6A and 6G to 6F). In
FIG. 3. Analysis of cell death in GDF11-treated limbs. Wing buds
and treated wings were then fixed at stage 24–25, sectioned longit
to the right. Beads are indicated by an asterisk. (A) Section throu
margin in a region that corresponds to the posterior necrotic zone. (
dying cells around the area where the bead was located. (C) Sect
TUNEL-positive cells undergoing apoptosis around the bead. (D) Hi
the bead. (E) Section of control wing bud showing TUNEL-positive
Section through a wing bud implanted with a control bead incubalimbs with a milder phenotype, Pax3 and MyoD transcripts
Copyright © 2000 by Academic Press. All rightwere still reduced in the area immediately around the bead
(Figs. 6D and 6I). Wing buds implanted with control beads
did not show any alterations in the expression patterns of
either Pax3 or MyoD (Figs. 6E and 6J). These results suggest
that GDF11 can inhibit myogenesis in the developing chick
limb. This lack of developing muscle may also contribute to
the truncated limb phenotype we observe.
To analyze the direct effect of GDF11 on myogenic cells,
e implanted with PBS-soaked or GDF11 beads at stage 21. Control
lly, and processed for TUNEL. Anterior is to the top and distal is
control wing bud showing TUNEL-positive cells in the posterior
ction through a GDF11-treated wing bud showing TUNEL-positive
hrough another GDF11-treated wing showing a large number of
wer view of C, showing a high concentration of dying cells around
s in the central region which corresponds to the opaque patch. (F)
PBS showing no increase in apoptotic cells around the bead.wer
udina
gh a
B) Se
ion t
gh-po
cellwe treated micromass cultures of chick wing mesenchyme
s of reproduction in any form reserved.
ells.
413Gdf11 Is a Negative Regulator in Developing Chick Limbwith GDF11 and compared these to cultures treated with
BMP-2, which has been shown to inhibit muscle cell
development in this system (Duprez et al., 1996). After 3
days, the cells were assayed immunohistochemically for
differentiated myoblasts using MF-20, a monoclonal anti-
body directed against sarcomeric myosin (Bader et al., 1982;
Swalla and Solursh, 1986). Control untreated cultures ex-
hibited many darkly stained MF-20-positive myoblasts that
clustered around the cartilage nodules (Fig. 4D). In contrast,
cultures treated with BMP-2 showed a significantly reduced
number of muscle cells (Fig. 4E) and in cultures treated with
GDF11, there were even fewer MF-20-positive cells (Fig.
4F). These data support our in vivo observations and suggest
that GDF11 has a negative effect on the differentiation of
mesenchymal cells in the limb into both the chondrogenic
FIG. 4. GDF11 inhibits chondrogenesis and myogenesis in limb m
limb buds were treated with 250 ng/ml BMP-2 or GDF11 and we
cartilage morphology or immunostained for MF-20, a marker of
blue-positive cartilage nodules. (B) BMP-2-treated micromass cult
GDF11-treated micromass cultures do not form cartilage nodules.
cells. (E) BMP-2-treated micromass cultures show a decreased n
cultures show a dramatically reduced number of MF-20-positive cand the myogenic lineages.
Copyright © 2000 by Academic Press. All rightThe Progress Zone Is Unaffected
by GDF11 Treatment
The progress zone is a region of proliferative, undifferen-
tiated mesenchymal cells located directly beneath the AER.
Cells move out of the progress zone to form cartilage
elements and are thought to acquire proper positional
information based on their residence time in the progress
zone. Cells that leave first adopt proximal fates (humerus or
femur) while those that exit later adopt more distal fates
(digits). If the initial size of the progress zone is reduced,
proximal limb structures are reduced or absent, but distal
structures are present and normal (Summerbell et al., 1973).
As the phenotype observed when the progress zone is
reduced is similar to what we see in GDF11 bead-implanted
chyme micromass cultures. Micromass cultures from stage 23–24
ed after 4 days and either stained with Alcian blue to determine
genic cells. (A) Control micromass cultures show many Alcian
form sheets of cartilage that stain strongly with Alcian blue. (C)
ontrol micromass cultures show many MF-20 positively staining
r of MF-20-positive muscle cells. (F) GDF11-treated micromassesen
re fix
myo
ures
(D) C
umbewings, we wanted to determine if treatment of the limb bud
s of reproduction in any form reserved.
414 Gamer et al.FIG. 5. Morphology of cartilage elements in GDF11-treated limbs. Histological sections of JB4 plastic resin-embedded whole-mount
preparations of day 9 humerus from (A) contralateral control and (E) GDF11-treated wings to show the cell morphology of the cartilage
elements. High-power views of the chondrocytes in the control humerus (B–D) and a severely affected GDF11-treated humerus (F–H).
Normal rounded cell zone (B) and the corresponding region at the end of the GDF11 humerus (F). Normal flattened cell zone (C) and the
corresponding region of the GDF11 humerus (G). Normal hypertrophic zone (D) and the corresponding region at the middle of the
GDF11-treated humerus (H).
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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416 Gamer et al.with GDF11 was affecting the size of the progress zone. We
analyzed the expression pattern of two markers of the
progress zone, Msx-1 and Msx-2 (Robert et al., 1991), by
whole-mount in situ hybridization. Interestingly, we found
that the expression patterns of both Msx-1 and Msx-2 were
unchanged in the GDF11-treated limbs (Fig. 7A and data
not shown), suggesting that the progress zone in the treated
wings is not affected by GDF11 and that the observed
shortening is due to another mechanism.
GDF11 Induces the Ectopic Expression
of Hoxd Genes
In order to understand the molecular mechanism of
GDF11 action in the limb, we analyzed the expression of
markers of appendicular skeletal patterning. We chose to
look at the effects of GDF11 treatment on the expression of
Hoxa and Hoxd genes based on two observations: (1) Gdf11
appears to colocalize with several of these Hox genes in the
distal mesenchyme of the early limb bud and (2) the
shortened skeletal elements in the GDF11 limbs resemble
those induced by retroviral misexpression of Hoxd-11 and
Hoxd-13 (Goff and Tabin, 1997). Beads incubated in GDF11
protein were implanted into stage 20–22 limb buds and
then collected for whole-mount in situ hybridization 24 h
later. Implantation of control beads in stage 20–22 wing
buds had no effect on the endogenous expression pattern of
any of the Hox genes we analyzed (data not shown). Figure
7B shows the normal expression pattern of Hoxd-13 in the
distal, posterior mesenchyme of a stage 23–24 contralateral
control wing bud. In Fig. 7C, strong ectopic expression of
Hoxd-13 is seen around the GDF11 bead in the proximal
and anterior region (n 5 5). Figure 7D reveals that GDF11
also induced a proximal and anterior expansion of the
endogenous posterior-distal domain of Hoxd-11 in stage 23
wing bud (n 5 5). In contrast, GDF11 had no effect on the
expression pattern of either Hoxa-11 or Hoxa-13 (data not
shown). Our results suggest that the developmental abnor-
malities observed in the limb as a result of exogenous
GDF11 may be mediated in part through a misregulation of
Hoxd genes.
GDF11 Causes Upregulation of Its Antagonist,
Follistatin
Members of the BMP family can modulate their own
activity through feedback mechanisms involving the induc-
tion of specific extracellular antagonists. For example, it
was recently shown that distal outgrowth of the chick limb
is controlled, in part, by a regulatory loop between BMPs
and gremlin (Merino et al., 1999b; Capdevila et al., 1999;
Mercader et al., 1999). Using Xenopus embryos, we have
shown previously that follistatin is a specific inhibitor of
GDF11 (Gamer et al., 1999). Since GDF11 appears to have a
strong effect on chick limb formation, we wanted to deter-
mine if a feedback mechanism existed to restrict GDF11
activity. In order to do this, we implanted beads soaked in p
Copyright © 2000 by Academic Press. All rightGDF11 protein into stage 21 limb buds and assayed for
changes in follistatin expression by whole-mount in situ
hybridization. In the contralateral controls, endogenous
follistatin is expressed proximally by muscle cells migrat-
ing into the limbs (Fig. 8A and Amthor et al., 1996). In the
GDF11-treated limbs, follistatin transcripts are ectopically
induced in an area directly surrounding the bead (n 5 8)
after 24 h (Figs. 8B and 8C). This effect was specific for
GDF11 as implantation of control beads did not alter
follistatin expression. These data show that GDF11, like
BMP-2 and BMP-4, can induce the expression of its own
antagonist, and this may help to control its activity during
limb development.
DISCUSSION
Gdf11 is a recently discovered member of the TGF-b
family that has been shown to be a key regulator of
patterning in the axial skeleton. Here we show that Gdf11
may also play an important role in the formation of the
appendicular skeleton in the chick.
During avian limb development, Gdf11 is strongly ex-
ressed in the distal mesenchyme of the progress zone and
ppears to be excluded from chondrogenic areas that will
ventually differentiate to form the limb skeleton. Exog-
nous application of GDF11 via bead implantation into the
imb bud causes severe shortening of the wing, with both
keletal elements and muscle being affected. The trunca-
ion of the developing limbs due to GDF11 treatment
ppears to be due to a complex mechanism which involves
n initial increase in apoptosis, followed by an inhibition of
hondrogenesis and skeletal element growth (due to mis-
egulation of Hox genes), as well as an inhibition of myo-
enesis (which may be due to cross reaction with GDF8
ignaling pathways). Our results suggest that Gdf11 may
unction during the formation of the chick limb in two
ays: first, to keep cells in the progress zone from differen-
iating and second, to help pattern the limb skeleton by
egulating Hox gene expression.
When beads incubated in GDF11 protein were implanted
nto stage 20–22 wing buds, the treated limbs were signifi-
antly shortened and the skeletal elements of the zeugopod
nd stylopod were truncated up to 50% of the length of the
ontrols. This dramatic reduction in limb size was detected
fter only 24 h of GDF11 exposure, at stage 24–25, when the
esenchymal cells are beginning to condense to form
artilage and the specific elements are still being specified.
ince Gdf11 is so highly expressed in the distal mesen-
hyme and GDF11 treatment causes limb shortening very
arly on, we reasoned that GDF11 might be working by
erturbing the size of the progress zone. Summerbell et al.
1973) showed that if the progress zone was made smaller, a
roperly patterned limb skeleton was formed but skeletal
lements were reduced in size. While this phenotype is
imilar to what we saw in the GDF11-treated wings, the
rogress zone of the GDF11-treated limbs appeared normal,
s of reproduction in any form reserved.
FIG. 7. Effects of GDF11 on Msx and Hoxd gene expression. Limb buds were implanted at stage 20–22 with beads soaked in GDF11
protein and embryos were fixed at day 5 and processed for whole-mount in situ hybridization. Dorsal views are shown with anterior to the
top. The location of the GDF11 beads is indicated by an arrowhead. (A) Expression of Msx-2 in contralateral control (right) and
GDF11-treated (left) wings at stage 24. There is no obvious change in the expression pattern of Msx-2 in the GDF11 bead-implanted wing.
(B) Normal expression of Hoxd-13 in contralateral control wing bud at stage 24. (C) Ectopic expression of Hoxd-13 around the bead in
GDF11-treated wing bud at stage 24. (D) Expression of Hoxd-11 in contralateral control (right) and GDF11-treated (left) wings at stage 24.
Note that the normal domain of Hoxd-11 had expanded proximally.
FIG. 8. GDF11 induces the expression of its own antagonist, follistatin. Stage 21 wing buds were implanted with GDF11-treated beads
and embryos were fixed at day 5 and processed for whole-mount in situ hybridization. Dorsal views are shown with anterior to the top and
distal to the left. (A) Normal expression pattern of follistatin in the migrating muscle cells (arrowhead) of a control stage 25 forelimb. (B
and C) Ectopic expression of follistatin around the bead (arrows) in GDF11-treated limbs at stage 25.
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418 Gamer et al.with no changes in cell proliferation or molecular markers.
Therefore, the early reduction in limb size is probably due
to another mechanism. We favor the idea that the early
decrease in size of the limb is due to an increase in cell
death caused by GDF11. This would reduce the initial
number of mesenchymal cells that form the limb and could
later contribute to truncations of the cartilage elements. It
is unclear whether the cell death induced by GDF11 is
happening directly or is an indirect consequence of cells not
receiving the appropriate signals to differentiate. At this
time, we prefer the latter explanation because, unlike BMP2
and 4, the expression pattern of Gdf11 does not correlate
ith the anterior necrotic zone, posterior necrotic zone, or
nterdigital mesenchyme, which are all areas of pro-
rammed cell death in the limb. In contrast, Gdf11 is highly
xpressed in an area that must stay proliferative and active
or limb outgrowth.
Our in vitro and in vivo data imply that the shortening
nd widening of the limbs we observed is also due to a
trong negative effect of GDF11 on chondrogenesis and
hondrocyte cell differentiation. We found that in high-
ensity micromass cultures of limb mesenchymal cells,
DF11 blocked the formation of cartilage nodules. This is
n contrast to other TGF-b family members, like TGF-b1,
TGF-b2, and BMP-2, which enhance chondrogenesis in
hese cultures (Kulyk et al., 1989; Roark and Greer, 1994).
n addition, histologic analysis of GDF11-treated skeletal
lements showed that GDF11 also affected chondrogenesis
n vivo. Chondrocytes in the GDF11-treated wings appear
mmature, with few if any hypertrophic chondrocytes
resent. During normal skeletal development, terminal
ifferentiation of hypertrophic chondrocytes results in a
ramatic increase in long-bone size due to an increase in
oth cell size and amount of surrounding cartilage matrix.
ur data suggest that the severe reduction in element size
e see in the GDF11-treated wings may be due, in part, to
he lack of hypertrophic cell differentiation. This negative
ffect on chondrogenesis correlates well with the observa-
ion that during the formation of the embryonic limb Gdf11
ppears to be excluded from regions of the wing or leg
ndergoing cartilage differentiation.
The truncation of the limb can also be partially a result of
DF11 inhibition of muscle development. When the dorsal
ctoderm is removed from early wing buds, myogenic cells
top proliferating and prematurely differentiate, exhausting
he precursor pool and preventing further muscle growth
Amthor et al., 1998). This eventually leads to limb trun-
ations in which both the stylopod and the zeugopod are
hortened (Amthor et al., 1998). This phenotype is very
imilar to what we see in the GDF11-treated wings, but the
uestion arises as to whether this is a specific effect of
DF11. The highly related GDF8 and GDF11 proteins
ould share a common receptor, or each of these molecules
ould bind and activate the other ligand’s receptor (Lee and
cPherron, 1999). Adult mice carrying a targeted disrup-
ion of Gdf8 exhibit a dramatic increase in skeletal muscle
ass (McPherron et al., 1997). Based on this phenotype, one
Copyright © 2000 by Academic Press. All rightould predict seeing a decrease in the amount of muscle
hen GDF8 is overexpressed. Interestingly, in the GDF11-
reated limbs, muscle development is inhibited and Pax3
nd MyoD are both downregulated. Our preliminary results
suggest that GDF8 and GDF11 induce equivalent pheno-
types in the chick limb (L. Gamer, K. Cox, and V. Rosen,
unpublished observations); therefore it will be very difficult
to distinguish the individual effects of each of these mol-
ecules until the GDF8 and GDF11 signaling pathways have
been identified.
The expression of Gdf11 during limb development in the
distal mesenchyme overlaps with the expression domains
of a number of factors that are thought to play major roles
in patterning the limb, including some of the Hox genes.
Hox genes have been shown to have an early role in
regulating the growth of undifferentiated limb mesen-
chyme and a later role in regulating the maturation of the
forming skeletal elements (Morgan and Tabin, 1994).
Misexpression of Hoxd-11 and Hoxd-13 by retroviral vec-
tors in the early chick limb leads to a decrease in the length
of the limb bones (Goff and Tabin, 1997), a phenotype very
similar to what we see with GDF11 treatment. When we
analyzed the GDF11-treated limbs, we found that both
Hoxd-11 and Hoxd-13 were ectopically induced around the
bead, and their normal distal domain of expression was
expanded proximally. The alterations in the shape of the
skeletal elements we are observing may be due, in part, to
the misexpression of Hoxd-11 and Hoxd-13 in regions
where they are not normally found, thus causing the limb
to be shorter and wider. Our data suggest that GDF11 may
act upstream of Hox genes in the chick limb to regulate
their expression during the patterning of the appendicular
skeleton. These data fit well with what is observed in the
Gdf11 knockout mice, in which Hox genes are misregu-
lated in the axial skeleton leading to actual homeotic
transformation of vertebral segments (McPherron et al.,
1999).
Our results demonstrate that GDF11 can affect chick
limb development. Given the conservation of signaling
pathways between the mouse and the chick during limb
patterning and formation, how do we then explain the
observations by McPherron et al. (1999) that the limb
skeleton appears unaffected in the Gdf11 null mice? We
suggest several possibilities. There may be compensation
by other members of the TGF-b superfamily that are
xpressed in the limb as seen in the BMP-6 and BMP-7
nockout mice (Solloway et al., 1998; Lou et al., 1995;
udley et al., 1996). Another possibility is that the pheno-
ype we observe is a result of exogenous GDF11 activating
dditional TGF-b/BMP signaling pathways involved in limb
formation. This seems unlikely for two reasons. First,
increased signaling through the BMP pathway via overex-
pression of constitutively active BMPR-1A and BMPR-1B in
early limb buds leads to dramatic expansion of chondrogen-
esis (Zou et al., 1997), an effect opposite to what we see
with GDF11 treatment. Alternatively, increased signaling
through an activin pathway either has no effect on skeletal
s of reproduction in any form reserved.
c
r
e
n
b
t
a
e
s
f
b
t
l
m
n
b
h
H
u
F
w
m
B
n
l
e
d
f
(
i
t
m
a
t
b
t
c
n
i
t
t
s
e
f
1
G
t
p
d
p
m
o
B
419Gdf11 Is a Negative Regulator in Developing Chick Limbdevelopment (Merino et al., 1999a) or results in increased
hondrogenesis (Jiang et al., 1993), again, the opposite of our
esults. Therefore we believe the inhibition of chondrogen-
sis and myogenesis we observe with GDF11 treatment is
ot an artifact of high localized expression of the protein
ut represents a previously undiscovered role for GDF11 in
he limb.
A surprising finding of our studies is that exogenous
pplication of GDF11 in the limb bud induces the ectopic
xpression of follistatin, an antagonist of GDF11. This
uggests that the activity of GDF11 is limited by negative
eedback. Strict control of the action of GDF11 appears to
e necessary for proper limb formation as we have shown
hat overexposure of mesenchymal cells to GDF11 causes
imb truncations and inhibits both chondrogenesis and
yogenesis. The upregulation of follistatin is most likely
ot a major contributing factor to the phenotype we observe
ecause implantation of follistatin beads at the same stage
as no effect on limb development (Merino et al., 1999a).
owever, we cannot rule out the possibility that follistatin
pregulation could block signaling by BMPs or activin.
eedback regulation of GDF11 in limb appears similar to
hat has been recently demonstrated for other BMP family
embers and their antagonists. When beads incubated in
MP4 are applied to developing somites, the expression of
oggin is upregulated, maintaining a balance between pro-
iferation and differentiation of embryonic muscle (Amthor
t al., 1999). In addition, induction of noggin has been
ocumented in both cultured rat osteoblasts and mouse
orelimb organ cultures treated with BMPs 2 and 7
Gazzerro et al.,1998; Nifuji and Noda, 1999). These data
mply that the coordinated regulation of BMPs/GDFs and
heir inhibitors may be essential for proper skeletal and
uscle development during embryogenesis. These results
lso suggest the possibility that in specific tissues, inhibi-
ors such as noggin and follistatin could act as inducible
inding proteins for BMPs, preventing overexposure of cells
o these potent growth factors.
Limb mesenchymal progenitor cells can give rise to
hondrocytes, osteoblasts, adipocytes, myoblasts, or con-
ective tissue. In micromass cultures, GDF11 is a potent
nhibitor of chondrogenesis and myogenesis. One impor-
ant question that arises from our studies is the identity of
he GDF11-treated cells—do they remain as mesenchymal
tem cells or are they pushed into another cell fate? Recent
vidence suggests that follistatin is able to inhibit tendon
ormation in the developing chick foot (D’Souza and Patel,
999). Since follistatin is an antagonist of GDF11—could
DF11 have the opposite effect and induce the formation of
endon? Our preliminary data from bead implantation ex-
eriments in the chick foot indicate that GDF11 induces a
ense connective tissue in an area around the bead that is
ositive for the early tendon marker EphA4 (L. Gamer, K.
Cox, and V. Rosen, unpublished observations). Future ex-
periments will address the role of GDF11 in tendon forma-
tion and patterning in the developing chick autopod and
Copyright © 2000 by Academic Press. All rightay further elucidate the function of GDF11 in the embry-
nic limb skeleton.
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